1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 10 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2007A review and critique of modelling in prioritising and designing screening programmesKarnon, J.; Goyder, E.; Tappenden, P.; McPhie, S.; Towers, I.; Brazier, J.; Madan, J.
2006Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancerDelea, T.; Karnon, J.; Smith, R.; Johnston, S.; Brandman, J.; Sung, J.; Goss, P.
2004Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.Karnon, J.; Peters, J.; Chilcott, J.; McGoogan, E.; Brewer, N.
2003A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy: for advanced breast cancer in postmenopausal patientsKarnon, J.; Jones, T.
2005Developing a relativities approach to valuing the prevention of non-fatal work-related accidents and ill healthKarnon, J.; Tsuchiya, A.; Dolan, P.
2007Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureDelea, T.; Karnon, J.; Goss, P.
2001A model for analyzing the cost of the main clinical events after lung transplantationSharples, L.; Taylor, G.; Karnon, J.; Caine, N.; Buxton, M.; McNeil, K.; Wallwork, J.
2005Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UKKarnon, J.; Brennan, A.; Pandor, A.; Fowkes, G.; Lee, A.; Gray, D.; Coshall, C.; Nicholls, C.; Akehurst, R.
2006Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: The UK perspectiveKarnon, J.; Delea, T.; Johnston, S.; Smith, R.; Brandman, J.; Sung, J.; Goss, P.
2009Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus CyclophosphamideLiubao, P.; Xiaomin, W.; Chongqing, T.; Karnon, J.; Gannong, C.; Jianhe, L.; Wei, C.; Xia, L.; Junhua, C.

Discover